TECH OUTLOOK 6OCTOBER - 2022EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comPharmaceutical manufacturers are under constant pressure to increase the pace at which they introduce successful drugs to the market. Engineers in the pharmaceutical industry are creating modular, continuous, and scalable processes and manufacturing environments to meet these demands while tackling cost and quality challenges head-on. Aiding them to make progressive strides in that direction are technologies like robotic process automation (RPA) and AI.Big pharma companies are adopting various technological trends driven by AI and RPA to gain a competitive advantage in their supply chain. According to research, the industry is expected to show an annual growth rate of 5.23 percent, resulting in a market volume of $1,431 billion by 2027.Personalized medicine or precision medicine is going to be its most advantageous outcome. With its approach to diagnosing, treating, and preventing diseases using a patient's genes and lifestyle, precision medicine will be a game-changer in ceasing adverse reactions. To put the spotlight on such key developments in the industry, Pharma Tech Outlook illustrates how the Pharma Manufacturing space is leveraging the latest technologies to formulate a safe and effective product that will change the pharma industry. This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Steven Beales, Senior Vice President, Safety Reporting at WCG, Jon Kallay, Senior Technology and Market Development Manager at Charles River Laboratories, and Kimberly Paris, SVP and Chief Compliance Officer at Quotient Sciences. They shed light on the areas to be considered when planning a customized clinical supply management solution, and how to implement fail-proof electronic document and quality management systems in pharma companies. In this edition of Pharma Tech Outlook, we also bring to you the story of the top pharma manufacturing solution providers facilitating unparalleled pharmaceutical technologies for pharma companies. In the list, Kinematica stands out for its ground-breaking and precise homogenizer technology to overcome the challenge of temperature control, cost, and energy efficiency in health and medicine. We also bring you the story of Nicos Group, which is an asset to pharma manufacturers for its modular cleanroom system and uncompromising quality standards. Through the following pages, we aim to shine a light on the innovative trends and latest developments in the pharma manufacturing industry. We would like to know your thoughts.Precision Medicine Set to Transform the Pharma SpaceTECH OUTLOOKTECH OUTLOOKCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.OCTOBER - 10 - 2022, Vol 08 - Issue 14 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com Disclaimer: * Some of the Insights are based on our interviews with CIOs and CXOsEditor-in-ChiefStacey SmithVisualizerRonald DonovanEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul Barbersales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Parley Meadow
< Page 5 | Page 7 >